Deregulated PI3K signaling and its relevance for chemoresistance in human breast cancer
TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy.
Acta Oncol 2014 Oct;53(10):1347-55. Epub 2014 jun 9
The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.
Expert Opin Pharmacother 2014 Apr;15(5):681-700. Epub 2014 feb 28
High PTEN gene expression is a negative prognostic marker in human breast cancers with preserved TP53 function
Breast Cancer Res Treat, 2017, accepted for publication
Activation of Akt characterizes estrogen receptor positive breast cancers exposed to anthracyklins
Breast Cancer Res Treat, submitted